Microfabrica
Develops high-volume production micro-scale additive manufacturing systems using proprietary electrochemical deposition (EFAB) technology, enabling complex metal structures with features as small as 40 microns for medical, aerospace, and semiconductor applications.
- CEO / Founder
- Eric C. Miller
- Team Size
- 51-200
- Stage
- Acquired
- Total Funding
- $62.6M
- Latest Round
- Acquired
- Key Investors
- Versant Ventures; Interwest Partners; Draper Fisher Jurvetson; Chevron Technology Ventures; DynaFund Ventures; Partech; Threshold Ventures; Technoprobe
Technology & Products
Key Products
High-resolution additive manufacturing systems for complex, microscopic metal parts, including semiconductor devices. Proprietary material: Valloy-120™.
Technological Advantage
Proprietary Electrochemical Additive Manufacturing (EFAB) process achieves 99.7% density in metal parts, protected by 49 patents in additive manufacturing and microfabrication (e.g., US patents held by team members).
Differentiation
Value Proposition
Reduces production lead times for micro-scale components from months to weeks, enables monolithic fabrication of multi-part assemblies eliminating manual assembly, and achieves tolerances within +/- 2 microns for high-precision applications in medical and aerospace.
How They Differentiate
3x higher precision (40-micron features vs. 100+ microns for typical metal AM) and 10x faster production scaling for micro-scale parts compared to traditional MEMS fabrication, with ability to produce multi-part assemblies monolithically.
Market & Competition
Target Customers
Medical device manufacturers, aerospace companies, semiconductor test equipment providers, and electronics firms requiring micro-scale precision parts.
Industry Verticals
Medical Devices; Aerospace; Semiconductor; Electronics
Competitors
Xidas; Stratasys Direct Manufacturing; Conrad Electronic
Growth & Milestones
Growth Metrics
Revenue estimated at $17.8M to $22.3M with 76-131 employees, serving medical, aerospace, and semiconductor sectors.
Major Milestones
Founded in 1999 as MemGen; Raised $22.5M Series B in 2008; Acquired by Technoprobe in 2019; Developed submillimeter forceps with US Endoscopy; Launched MICA Freeform platform
Notable Customers
US Endoscopy (for submillimeter forceps); Semiconductor test equipment manufacturers (via Technoprobe integration)